High Rate of Adverse Events in Patients Receiving Oral Antimicrobials Under a COpAT Monitoring Protocol
Open Access
- 19 September 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
Abstract
We conducted a retrospective review to characterize adverse events in patients receiving oral linezolid, trimethoprim-sulfamethoxazole, voriconazole, and itraconazole monitored under an outpatient parenteral antimicrobial therapy program. Among 118 patients, 61% incurred at least 1 adverse event during treatment, highlighting the need for evidence-based monitoring protocols for complex outpatient antimicrobial therapy.Keywords
This publication has 12 references indexed in Scilit:
- Implementing Oral Antibiotics for Bone and Joint Infections: Lessons Learned and Opportunities for ImprovementOpen Forum Infectious Diseases, 2024
- Making the EHR Work for You—Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic TherapyOpen Forum Infectious Diseases, 2024
- Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2022
- Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United StatesAntimicrobial Stewardship & Healthcare Epidemiology, 2022
- Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort studyJournal of Antimicrobial Chemotherapy, 2022
- From ‘OPAT’ to ‘COpAT’: implications of the OVIVA study for ambulatory management of bone and joint infectionJournal of Antimicrobial Chemotherapy, 2019
- Oral versus Intravenous Antibiotics for Bone and Joint InfectionNew England Journal of Medicine, 2019
- Partial Oral versus Intravenous Antibiotic Treatment of EndocarditisNew England Journal of Medicine, 2019
- 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial TherapyaClinical Infectious Diseases, 2018
- Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programmeJournal of Antimicrobial Chemotherapy, 2013